Instead of viewing obesity as one uniform condition, experts now recognize that it can arise from multiple biological patterns. Understanding that difference could finally change how we approach treatment altogether. The post It’s the End Of the Line for One‑Size‑Fits‑All Weight Loss appeared first on MedCity News.
Approval of Syndax’s Revuforj for acute leukemia makes the twice-daily pill the first in a new class of drugs that block a cancer-driving protein called menin. Other companies developing menin inhibitors include Kura Oncology, Biomea Fusion, and Johnson & Johnson subsidiary Janssen. The post Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval appeared first…
Randomized controlled trials are the gold standard for evaluating treatment efficacy, but effectiveness in the real-world may vary. One reason for this is that clinical trials often have stricter inclusion criteria than is the case for the target treated population. Policymakers, payers, and clinicians may wonder how well the results from the narrower clinical trial…
CMS Innovation Center leading the way on including patient-reported measures in payment models
The ruling, which limits federal agencies’ power to interpret ambiguous laws, now leaves crucial legislation like the Mental Health Parity and Addiction Equity Act vulnerable to court challenges, potentially unraveling years of hard-won progress. The post Supreme Court’s Chevron Decision Threatens Decades of Progress in Access to Mental Health Care appeared first on MedCity News.
The organizations that will thrive in this environment are those that invest in resilience — the capacity to adapt, absorb strain, and maintain performance in the face of volatility. The post Success in Chaos: Building Resilient Systems for an Unpredictable Future appeared first on MedCity News.
Spending on digital health has increased rapidly over past two years
How do you write a good grant proposal? How do you write a good proposal for any type of project? Jim Olds– the former head of NSF’s Biological Sciences Directorate –provides some fantastic advice in his post “What Grant Reviewers Actually Look For (and What They Ignore)“. He distills what grant reviewers want into 5…
Review of individuals’ data that may have been involved in ransomware attack has been completed
Early diagnosis through blood tests buys invaluable time – for patients and their families to plan, seek support, make informed decisions about their difficult care journey and, perhaps most importantly, be together. The post Why We Urgently Need More Widely Available Tests for Alzheimer’s Disease appeared first on MedCity News.